Articles related to TESTING/LABS

With a negative predictive value of 97%, the new breath test for colorectal cancer represents a significant advancement in non-invasive cancer diagnostics.

Explore this comprehensive guide on evaluating a low anion gap and enhance your diagnostic capabilities. Don’t miss out on the opportunity to learn more.

Discover how Labcorp’s new ATN Profile can revolutionize your approach to diagnosing Alzheimer’s disease.

Discover how the FDA-approved Invitae’s Common Hereditary Cancers Panel can enhance your approach to early cancer detection and personalized treatment planning.

Discover how MPO testing can offer a more comprehensive understanding of your patients’ health risks, including mortality beyond cardiovascular disease.

Curious about the best approach for cardiovascular risk assessment in asymptomatic adults? Dive into this quiz to explore evidence-based recommendations.